[SCHEDULE 13G] Community Health Systems, Inc. SEC Filing
Nomura Holdings, Inc. and its subsidiary Nomura Global Financial Products, Inc. reported beneficial ownership of 7,271,079 shares of Community Health Systems, Inc. The filing states these shares represent 5.2% of CYH's common stock outstanding based on 140,119,616 shares as of June 30, 2025. All reported shares are held with shared voting and shared dispositive power; neither reporting person claims sole voting or dispositive power. The statement is filed on a Schedule 13G and includes certifications that the holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Signatures and exhibits (Joint Filing Agreement and Subsidiaries) are included.
Nomura Holdings, Inc. e la sua controllata Nomura Global Financial Products, Inc. hanno dichiarato la titolarit脿 beneficiaria di 7.271.079 azioni di Community Health Systems, Inc. La comunicazione indica che tali azioni rappresentano il 5,2% del capitale sociale ordinario di CYH, calcolato su 140.119.616 azioni in circolazione al 30 giugno 2025. Tutte le azioni dichiarate sono detenute con potere di voto condiviso e potere dispositivio condiviso; nessuno dei soggetti segnalanti rivendica potere di voto o dispositivio esclusivo. La dichiarazione 猫 presentata su un Schedule 13G e include le certificazioni che le partecipazioni sono detenute nell'ambito dell'ordinaria attivit脿 commerciale e non con l'intento di modificare o influenzare il controllo dell'emittente. Sono allegate firme ed exhibit (Accordo di Deposito Congiunto e Controllate).
Nomura Holdings, Inc. y su filial Nomura Global Financial Products, Inc. comunicaron la propiedad beneficiaria de 7.271.079 acciones de Community Health Systems, Inc. El documento indica que estas acciones representan el 5,2% del capital social ordinario de CYH, sobre la base de 140.119.616 acciones en circulaci贸n a 30 de junio de 2025. Todas las acciones informadas se mantienen con voto compartido y poder dispositivo compartido; ninguno de los informantes reclama poder de voto o dispositivo exclusivo. La declaraci贸n se presenta en un Schedule 13G e incluye certificaciones de que las participaciones se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor. Se adjuntan firmas y anexos (Acuerdo de Presentaci贸n Conjunta y Filiales).
雲鸽霛� 頇�霐╈姢(Nomura Holdings, Inc.)鞕� 攴� 鞛愴殞靷� 雲鸽霛� 旮�搿滊矊 韺岇澊雮胳厹 頂勲雿曧姼(Nomura Global Financial Products, Inc.)電� 旎る雼堩嫲 項姢 鞁滌姢韰滌(Community Health Systems, Inc.)鞚� 鞙犾澋靻岇湢欤茧靹� 7,271,079欤茧ゼ 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨姷雼堧嫟. 鞁犼碃靹滌棎 霐半ゴ氅� 鞚� 欤检嫕鞚� 2025雲� 6鞗� 30鞚� 旮办 氚滍枆欤检嫕靾� 140,119,616欤茧ゼ 旮办鞙茧 CYH 氤错喌欤检潣 5.2%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 氇摖 欤检嫕鞚� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞙茧 氤挫湢霅橃柎 鞛堨溂氅�, 鞏措姁 氤搓碃鞚鸽弰 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 欤检灔頃橃 鞎婌姷雼堧嫟. 鞚� 氤搓碃靹滊姅 Schedule 13G搿� 鞝滌稖霅橃棃鞙茧┌ 氤挫湢臧� 鞝曥儊 鞓侅梾頇滊彊鞚� 氩旍渼 雮挫棎 鞛堨溂氅� 氚滍枆鞚胳棎 雽�頃� 歆�氚瓣秾 氤�瓴� 霕愲姅 鞓來枼 鞚橂弰臧� 鞐嗢潓鞚� 鞚胳頃橂姅 靹滊毳� 韽暔頃╇媹雼�. 靹滊獏 氚� 歃濍箼靹滊(瓿惦彊 鞝滌稖 頃╈潣靹� 氚� 鞛愴殞靷� 氇╇)臧� 觳秬霅橃柎 鞛堨姷雼堧嫟.
Nomura Holdings, Inc. et sa filiale Nomura Global Financial Products, Inc. ont d茅clar茅 d茅tenir la propri茅t茅 b茅n茅ficiaire de 7 271 079 actions de Community Health Systems, Inc. Le d茅p么t indique que ces actions repr茅sentent 5,2% du capital social ordinaire de CYH, sur la base de 140 119 616 actions en circulation au 30 juin 2025. Toutes les actions d茅clar茅es sont d茅tenues avec pouvoir de vote partag茅 et pouvoir de disposition partag茅 ; aucun des d茅clarants ne revendique de pouvoir de vote ou de disposition exclusif. La d茅claration est d茅pos茅e sur un Schedule 13G et contient des certifications selon lesquelles les participations sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Signatures et annexes (Accord de d茅p么t conjoint et Filiales) sont inclus.
Nomura Holdings, Inc. und ihre Tochtergesellschaft Nomura Global Financial Products, Inc. meldeten wirtschaftliches Eigentum an 7.271.079 Aktien von Community Health Systems, Inc. Die Meldung besagt, dass diese Aktien 5,2% des ausstehenden Stammkapitals von CYH darstellen, basierend auf 140.119.616 Aktien zum 30. Juni 2025. Alle gemeldeten Aktien werden mit gemeinsamen Stimmrechten und gemeinsamer Verf眉gungsgewalt gehalten; keiner der Meldenden beansprucht ausschlie脽liches Stimm- oder Verf眉gungsrecht. Die Erkl盲rung wurde auf einem Schedule 13G eingereicht und enth盲lt Best盲tigungen, dass die Beteiligungen im Rahmen der gew枚hnlichen Gesch盲ftst盲tigkeit gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dienen. Unterschriften und Anlagen (Gemeinsame Einreichungsvereinbarung und Tochtergesellschaften) sind beigef眉gt.
- Disclosure of a material minority stake: 7,271,079 shares (5.2%) reported, improving transparency for investors
- Passive holder certification: Item 10 states holdings are in the ordinary course of business and not for control, clarifying intent
- Clear attribution to subsidiary: Shares attributed to Nomura Global Financial Products, Inc., with parent filing linkage via exhibits
- None.
Insights
TL;DR: A 5.2% passive stake by Nomura group is disclosed, signaling a meaningful minority position without an expressed intent to control.
The filing reports 7,271,079 shares, equivalent to 5.2% of CYH outstanding stock as of June 30, 2025. Holdings are recorded as shared voting and shared dispositive power via Nomura Global Financial Products, Inc., a wholly owned subsidiary of Nomura Holdings. The use of Schedule 13G and the Item 10 certification indicate the position is presented as passive and held in the ordinary course of business rather than to influence control. For investors, this is a material disclosure of concentration but, based on the filing, not an active control attempt.
TL;DR: The Schedule 13G filing documents a material minority stake and includes the standard non-control certification.
The report identifies Nomura Holdings and Nomura Global Financial Products, Inc. as reporting persons, with shared voting and dispositive powers over the reported shares. The inclusion of a Joint Filing Agreement (Exhibit A) and Subsidiaries listing (Exhibit B) follows typical disclosure practice when a parent and subsidiary report together. The Item 10 certification explicitly states the shares were not acquired to change or influence control, consistent with a passive investor profile under Rule 13d-1(b)/(c).
Nomura Holdings, Inc. e la sua controllata Nomura Global Financial Products, Inc. hanno dichiarato la titolarit脿 beneficiaria di 7.271.079 azioni di Community Health Systems, Inc. La comunicazione indica che tali azioni rappresentano il 5,2% del capitale sociale ordinario di CYH, calcolato su 140.119.616 azioni in circolazione al 30 giugno 2025. Tutte le azioni dichiarate sono detenute con potere di voto condiviso e potere dispositivio condiviso; nessuno dei soggetti segnalanti rivendica potere di voto o dispositivio esclusivo. La dichiarazione 猫 presentata su un Schedule 13G e include le certificazioni che le partecipazioni sono detenute nell'ambito dell'ordinaria attivit脿 commerciale e non con l'intento di modificare o influenzare il controllo dell'emittente. Sono allegate firme ed exhibit (Accordo di Deposito Congiunto e Controllate).
Nomura Holdings, Inc. y su filial Nomura Global Financial Products, Inc. comunicaron la propiedad beneficiaria de 7.271.079 acciones de Community Health Systems, Inc. El documento indica que estas acciones representan el 5,2% del capital social ordinario de CYH, sobre la base de 140.119.616 acciones en circulaci贸n a 30 de junio de 2025. Todas las acciones informadas se mantienen con voto compartido y poder dispositivo compartido; ninguno de los informantes reclama poder de voto o dispositivo exclusivo. La declaraci贸n se presenta en un Schedule 13G e incluye certificaciones de que las participaciones se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor. Se adjuntan firmas y anexos (Acuerdo de Presentaci贸n Conjunta y Filiales).
雲鸽霛� 頇�霐╈姢(Nomura Holdings, Inc.)鞕� 攴� 鞛愴殞靷� 雲鸽霛� 旮�搿滊矊 韺岇澊雮胳厹 頂勲雿曧姼(Nomura Global Financial Products, Inc.)電� 旎る雼堩嫲 項姢 鞁滌姢韰滌(Community Health Systems, Inc.)鞚� 鞙犾澋靻岇湢欤茧靹� 7,271,079欤茧ゼ 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨姷雼堧嫟. 鞁犼碃靹滌棎 霐半ゴ氅� 鞚� 欤检嫕鞚� 2025雲� 6鞗� 30鞚� 旮办 氚滍枆欤检嫕靾� 140,119,616欤茧ゼ 旮办鞙茧 CYH 氤错喌欤检潣 5.2%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 氇摖 欤检嫕鞚� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞙茧 氤挫湢霅橃柎 鞛堨溂氅�, 鞏措姁 氤搓碃鞚鸽弰 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 欤检灔頃橃 鞎婌姷雼堧嫟. 鞚� 氤搓碃靹滊姅 Schedule 13G搿� 鞝滌稖霅橃棃鞙茧┌ 氤挫湢臧� 鞝曥儊 鞓侅梾頇滊彊鞚� 氩旍渼 雮挫棎 鞛堨溂氅� 氚滍枆鞚胳棎 雽�頃� 歆�氚瓣秾 氤�瓴� 霕愲姅 鞓來枼 鞚橂弰臧� 鞐嗢潓鞚� 鞚胳頃橂姅 靹滊毳� 韽暔頃╇媹雼�. 靹滊獏 氚� 歃濍箼靹滊(瓿惦彊 鞝滌稖 頃╈潣靹� 氚� 鞛愴殞靷� 氇╇)臧� 觳秬霅橃柎 鞛堨姷雼堧嫟.
Nomura Holdings, Inc. et sa filiale Nomura Global Financial Products, Inc. ont d茅clar茅 d茅tenir la propri茅t茅 b茅n茅ficiaire de 7 271 079 actions de Community Health Systems, Inc. Le d茅p么t indique que ces actions repr茅sentent 5,2% du capital social ordinaire de CYH, sur la base de 140 119 616 actions en circulation au 30 juin 2025. Toutes les actions d茅clar茅es sont d茅tenues avec pouvoir de vote partag茅 et pouvoir de disposition partag茅 ; aucun des d茅clarants ne revendique de pouvoir de vote ou de disposition exclusif. La d茅claration est d茅pos茅e sur un Schedule 13G et contient des certifications selon lesquelles les participations sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Signatures et annexes (Accord de d茅p么t conjoint et Filiales) sont inclus.
Nomura Holdings, Inc. und ihre Tochtergesellschaft Nomura Global Financial Products, Inc. meldeten wirtschaftliches Eigentum an 7.271.079 Aktien von Community Health Systems, Inc. Die Meldung besagt, dass diese Aktien 5,2% des ausstehenden Stammkapitals von CYH darstellen, basierend auf 140.119.616 Aktien zum 30. Juni 2025. Alle gemeldeten Aktien werden mit gemeinsamen Stimmrechten und gemeinsamer Verf眉gungsgewalt gehalten; keiner der Meldenden beansprucht ausschlie脽liches Stimm- oder Verf眉gungsrecht. Die Erkl盲rung wurde auf einem Schedule 13G eingereicht und enth盲lt Best盲tigungen, dass die Beteiligungen im Rahmen der gew枚hnlichen Gesch盲ftst盲tigkeit gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dienen. Unterschriften und Anlagen (Gemeinsame Einreichungsvereinbarung und Tochtergesellschaften) sind beigef眉gt.
FAQ
How many shares of CYH does Nomura report owning?
What percentage of CYH does the reported stake represent?
Which Nomura entities filed the Schedule 13G for CYH?
Does the filing indicate Nomura intends to influence control of CYH?
What voting and dispositive power is reported over the CYH shares?
When were the signatures on the filing executed?
